Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of April 2020. The report was signed by Zhang Rui (Kerrie), Chief Financial Officer, on April 1, 2020. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The content is limited to the cover page, signature block, and exhibit index.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Press Release) for actual financial results or operational updates, as the cover page contains no data.
- Confirm the discrepancy between the request metadata ("Akso Health Group") and the registrant name in the filing ("Hexindai Inc.").
- Review the full press release to assess any material events occurring in April 2020.